EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma

Fengli Guo, Guiming Fu, Fangxuan Li, Yitong Hua, Zhongyu Wang, Xiangqian Zheng, Jingzhu Zhao, Ming Gao

World Journal of Surgical Oncology · 06.05.2024 · 22 (1)

DOI: 10.1186/s12957-024-03397-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgical Oncology, online erschienen am 06.05.2024. Verfasst von Fengli Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Nati…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Calcitonin, Carcinoma, Neuroendocrine, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medullary thyroid carcinoma (MTC) is a malignant tumor with low incidence. Currently, most studies have focused on the prognostic risk factors of MTC, whatever, time kinetic and risk factors related to calcitonin normalization (CN) and biochemical persistence/recurrence (BP) are yet to be elucidated.

Methods

A retrospective study was conducted for 190 MTC patients. Risk factors related to calcitonin normalization (CN) and biochemical persistence/recurrence (BP) were analyzed. The predictors of calcitonin normalization time (CNT) and biochemical persistent/recurrent time (BPT) were identified. Further, the prognostic roles of CNT and BPT were also demonstrated.

Results

The 5- and 10-year DFS were 86.7% and 70.2%, respectively. The 5- and 10-year OS were 97.6% and 78.8%, respectively. CN was achieved in 120 (63.2%) patients, whereas BP was presented in 76 (40.0%) patients at the last follow up. After curative surgery, 39 (32.5%) and 106 (88.3%) patients achieved CN within 1 week and 1 month. All patients who failed to achieve CN turned to BP over time and 32/70 of them developed structural recurrence. The median time of CNT and BPT was 1 month (1 day to 84 months) and 6 month (3 day to 63months), respectively. LNR > 0.23 and male gender were independent predictors for CN and BP. LNR > 0.23 (Hazard ratio (HR), 0.24; 95% CI,0.13–0.46; P < 0.01) and male gender (HR, 0.65; 95% CI, 0.42–0.99; P = 0.045) were independent predictors for longer CNT. LNR > 0.23 (HR,5.10; 95% CI,2.15–12.11; P < 0.01) was still the strongest independent predictor followed by preoperative serum Ctn > 1400ng/L (HR,2.34; 95% CI,1.29–4.25; P = 0.005) for shorter BPT. In survival analysis, primary tumor size > 2 cm (HR, 5.81; 95% CI,2.20-15.38; P < 0.01), CNT > 1 month (HR, 5.69; 95% CI, 1.17–27.61; P = 0.031) and multifocality (HR, 3.10; 95% CI, 1.45–6.65; P = 0.004) were independent predictor of DFS.

Conclusion

Early changes of Ctn after curative surgery can predict the long-term risks of biochemical and structural recurrence, which provide a useful real-time prognostic information. LNR significantly affect the time kinetic of biochemical prognosis. Tumor burden and CNT play a crucial role in MTC survival, the intensity of follow-up must be tailored accordingly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCalcitoninCarcinoma, NeuroendocrineNeoplasm Recurrence, LocalThyroidectomyHumansMaleFemaleRetrospective StudiesMiddle AgedPrognosisAdultFollow-Up StudiesAgedSurvival RateBiomarkers, TumorYoung AdultAdolescentRisk FactorsTime Factors

Stichwörter der Autor:innen

Biochemical persistenceBiochemical recurrenceCalcitoninMedullary thyroid carcinomaStructural recurrence

Substanzen

CalcitoninBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research…
  • Department of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, China.
  • Department of Thyroid-otolaryngology, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of cancer prevention, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, Tianjin, China. headandneck2008@126.com.
  • Tianjin Key Laboratory of General Surgery in construction, Tianjin Union Medical Center, Tianjin, China. headandneck2008@126.com.

Zitieren

APA

Guo, F., Fu, G., Li, F., Hua, Y., Wang, Z., Zheng, X., Zhao, J., & Gao, M. (2024). Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma. World Journal of Surgical Oncology, 22(1). https://doi.org/10.1186/s12957-024-03397-3

Vancouver

Guo F, Fu G, Li F, Hua Y, Wang Z, Zheng X, et al. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma. World Journal of Surgical Oncology. 2024;22(1). doi:10.1186/s12957-024-03397-3

BibTeX
@article{Guo2024,
  author = {Guo, Fengli and Fu, Guiming and Li, Fangxuan and Hua, Yitong and Wang, Zhongyu and Zheng, Xiangqian and Zhao, Jingzhu and Gao, Ming},
  title = {Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma},
  journal = {World Journal of Surgical Oncology},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12957-024-03397-3}
}
Kostenlos starten →